Benjamin P. Saylor
Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.
Product Preview: Agent reduces urinary oxalate excretion in stone patients
Products in the pipeline for prostate cancer, bladder cancer, and much more.
Product Preview: Liquid Bx accurately identifies high-grade PCa
Products in the pipeline for prostate cancer, bladder cancer, stress urinary incontinence, chronic prostatitis/chronic pelvic pain syndrome, hypoactive sexual desire disorder.
Number of sexual partners linked to PCa risk
The number of sexual partners a man has could be related to risk of being diagnosed with prostate cancer, Canadian researchers report.
Recession may have prompted vasectomy increase
A study presented at the American Society for Reproductive Medicine annual meeting in Honolulu suggests a possible link between the recession of 2007-2009 and increasing vasectomy rates in the United States.
FDA OKs urinary prosthesis, lymphatic mapping agent
In separate actions, the FDA allowed the marketing of a urinary prosthesis for women and approved a supplemental new drug application for a lymphatic mapping agent.
(Slideshow) Iris Cantor Men's Health Center
Take a tour of Iris Cantor Men’s Health Center at NewYork-Presbyterian/Weill Cornell with this slideshow.
AUA IC/BPS guideline update highlights new data
The AUA has updated its guideline on interstitial cystitis/bladder pain syndrome, with changes primarily focusing on aspects of treatment for a condition that affects three to eight million women and one to four million men in the United States.
USPSTF PSA grade has ‘minimal’ impact on screening
The effect of the U.S. Preventive Services Task Force’s controversial grade “D” recommendation regarding PSA-based screening for prostate cancer “has been minimal at best,” according to a research letter that also shows a “shocking” level of statewide variance in screening, a leading prostate cancer expert said.
PCa test predicts aggressiveness, influences treatment
The Decipher Prostate Cancer Classifier test predicts disease aggressiveness, influences treatment decisions, and predicts which patients may benefit from post-prostatectomy radiation therapy, according to findings from three studies presented at the American Society for Radiation Oncology annual meeting in San Francisco.
Study: Ultrasound over CT for initial stone Dx
Ultrasound should be the initial diagnostic imaging test utilized for diagnosing kidney stones in order to reduce the higher radiation exposure associated with computed tomography, say the authors of a recent study.

Poll